Michael Jain

50PUBLICATIONS

297CO-AUTHORS

Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (50)

Sort by Publication Date:

|Jul 08, 2026

Identification of an optimal absolute lymphocyte count at leukapheresis in patients with lymphoma treated with CART.

|Jun 20, 2026

Expanded antigen-specific donor regulatory T cells for GVHD prevention.

|Apr 15, 2026

Spectrum, pathobiology, mechanistic insights and diagnostic challenges of post-CAR T cell therapy lymphoproliferative disorders.

|Feb 11, 2026

Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies.

Rawan G Faramand, Zhuoer Xie, Michael D Jain

|Sep 11, 2025

Immune dysfunction after cancer remission: scar or disease?

Michael D Jain, Jonathan Cools-Lartigue

|Aug 26, 2025

Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma.

Michael Winkelmann, Sandeep S Raj, Michael D Jain

Pageof 9

Frequent Collaborators

15 joint publications

Marco L Davila

15 joint publications

Frederick Locke

11 joint publications

Marion Subklewe

10 joint publications

Taiga Nishihori

Sattva S Neelapu

Aleksandr Lazaryan

Julio Chavez

Christina Bachmeier

David Miklos

Xuefeng Wang

Frequent Collaborators

15 joint publications

Marco L Davila

15 joint publications

Frederick Locke

11 joint publications

Marion Subklewe

10 joint publications

Taiga Nishihori